Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/25192
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jannathul Firdous | - |
dc.contributor.author | ATM Emdadul Haque | - |
dc.contributor.author | Karpagam T | - |
dc.contributor.author | Varalakshmi B | - |
dc.contributor.author | Bharathi V | - |
dc.contributor.author | Resni Mona | - |
dc.contributor.author | Noorzaid Muhamad | - |
dc.contributor.author | (UniKL RCMP) | - |
dc.date.accessioned | 2021-11-22T05:46:49Z | - |
dc.date.available | 2021-11-22T05:46:49Z | - |
dc.date.issued | 2020-03 | - |
dc.identifier.citation | Jannathul Firdous, ATM Emdadul Haque, Karpagam T, Varalakshmi B, Bharathi V, Resni Mona, & Noorzaid Muhamad. (2020). COVID-19 associated thromboembolism: causing the respiratory failure. International Journal of Research in Pharmaceutical Sciences, 11(SPL1), 1303–1306. https://doi.org/10.26452/ijrps.v11ispl1.3624 | en_US |
dc.identifier.issn | 09757538 | - |
dc.identifier.uri | https://pharmascope.org/index.php/ijrps/article/view/3624 | - |
dc.identifier.uri | http://hdl.handle.net/123456789/25192 | - |
dc.description.abstract | Coronavirus disease 2019 (COVID-19) has recently emerged in China and caused a global pandemic. WHO announced that COVID-19 could be charac-terised as a pandemic due to unprecedented swift global spread and severity of the outbreak. When infected with the virus, patients usually have a fever, dry cough, dyspnoea, myalgia, headache and sometimes diarrhoea. Updates on molecular characteristics of SARS-CoV-2, treatment and epidemiological control are more important to help optimise the disease control measures Thrombotic complication is an essential issue in patients infected with COVID-19. Concomitant venous thromboembolism (VTE) seems to be a potential cause of unexplained deaths in COVID-19 cases. Thrombocytopenia, elevated D-dimer, prolonged prothrombin time, and disseminated intravascular coagulation are the clinical findings related to such condition. In China, anticoagu-lant therapy in severe COVID-19 was suggested for improving outcome. Studies showed the urgency for VTE diagnostic strategies. Aetiology may be mul-tifactorial, and therefore, we review the available literature relevant to acute venous thromboembolism associated with novel coronavirus infection. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | J. K. Welfare and Pharmascope Foundation | en_US |
dc.subject | Anticoagulants | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | D-dimer | en_US |
dc.subject | Interleukin | en_US |
dc.subject | Venous Thromboembolism | en_US |
dc.title | COVID-19 associated thromboembolism: Causing the respiratory failure. | en_US |
dc.type | Article | en_US |
Appears in Collections: | Journal Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
COVID-19 associated thromboembolis.pdf | 178.56 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.